| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
110,186 |
99,838 |
$485K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
13,130 |
13,010 |
$161K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
4,829 |
4,720 |
$140K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
17,158 |
17,017 |
$138K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
5,666 |
5,524 |
$136K |
| G9920 |
Screening performed and negative |
16,845 |
16,760 |
$135K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
10,193 |
10,054 |
$84K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
13,013 |
12,903 |
$78K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
21,766 |
21,683 |
$54K |
| 96156 |
|
3,624 |
3,502 |
$41K |
| 92551 |
|
36,963 |
36,735 |
$39K |
| 0001A |
|
974 |
972 |
$39K |
| 0002A |
|
891 |
891 |
$36K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
5,756 |
5,578 |
$27K |
| 90700 |
|
9,831 |
9,697 |
$15K |
| D1206 |
Topical application of fluoride varnish |
9,140 |
9,057 |
$15K |
| 90713 |
|
8,107 |
7,994 |
$14K |
| 90658 |
|
15,317 |
15,274 |
$13K |
| 90648 |
|
6,995 |
6,851 |
$13K |
| 90670 |
|
5,897 |
5,797 |
$10K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,309 |
1,304 |
$9K |
| 85018 |
|
49,448 |
48,565 |
$9K |
| 90680 |
|
2,976 |
2,912 |
$7K |
| 90744 |
|
4,021 |
3,938 |
$7K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
733 |
732 |
$7K |
| 90649 |
|
4,544 |
4,520 |
$7K |
| 90734 |
|
5,639 |
5,630 |
$6K |
| 90480 |
|
136 |
136 |
$5K |
| 90716 |
|
3,729 |
3,685 |
$5K |
| 83655 |
|
5,112 |
5,028 |
$5K |
| 90633 |
|
4,117 |
4,048 |
$5K |
| 90707 |
|
3,615 |
3,567 |
$5K |
| 90620 |
|
3,280 |
3,272 |
$4K |
| 86580 |
|
29,344 |
29,067 |
$4K |
| 91319 |
|
98 |
98 |
$4K |
| 99188 |
|
2,358 |
2,303 |
$4K |
| 91320 |
|
114 |
114 |
$4K |
| 81002 |
|
20,296 |
20,086 |
$3K |
| 90715 |
|
2,688 |
2,681 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
6,467 |
4,026 |
$3K |
| 90651 |
|
3,554 |
3,537 |
$3K |
| 99384 |
|
40 |
40 |
$3K |
| 94010 |
|
2,149 |
2,145 |
$2K |
| 90677 |
|
796 |
791 |
$2K |
| 90657 |
|
2,344 |
2,330 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,497 |
4,404 |
$2K |
| 0003A |
|
44 |
44 |
$2K |
| 99381 |
|
12 |
12 |
$1K |
| 94664 |
|
2,339 |
2,336 |
$1K |
| 91318 |
|
28 |
27 |
$1K |
| 90656 |
|
731 |
721 |
$675.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
717 |
705 |
$633.19 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
106 |
103 |
$102.50 |
| 17000 |
|
27 |
27 |
$69.80 |
| 69210 |
|
77 |
77 |
$45.36 |
| 99173 |
|
4,142 |
4,139 |
$29.46 |
| 94060 |
|
42 |
42 |
$26.75 |
| 96127 |
|
586 |
574 |
$24.05 |
| 99177 |
|
15,600 |
15,573 |
$0.00 |
| 99072 |
|
137 |
132 |
$0.00 |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
12 |
12 |
$0.00 |